
OPRX
OptimizeRx Corporation
$20.49
+$0.88(+4.49%)
73
Overall
60
Value
83
Tech
76
Quality
Market Cap
$390.61M
Volume
256.56K
52W Range
$3.78 - $22.25
Target Price
$18.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $7.2M | $7.8M | $12.1M | $21.2M | $24.6M | $43.3M | $61.3M | $62.5M | $71.5M | $92.1M | ||
| Total Revenue | $7.2M | $6.2M | $12.1M | $21.2M | $24.6M | $43.3M | $61.3M | $62.5M | $71.5M | $92.1M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $3.6M | $3.4M | $6.2M | $-9.0M | $-9.2M | $19.2M | $25.7M | $23.5M | $28.6M | $32.7M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $3.6M | $4.3M | $6.0M | $12.2M | $15.4M | $24.1M | $35.6M | $39.0M | $42.9M | $59.4M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-4.2M | $-5.9M | $-8.1M | $-12.0M | $-19.1M | $26.2M | $35.3M | $51.3M | $69.3M | $73.1M | ||
| Research & Development | $3.6M | -- | -- | -- | $-1.6M | $3.2M | -- | -- | -- | -- | ||
| Research Expense | $3.6M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling, General & Administrative | -- | $5.1M | $6.9M | $9.2M | $15.6M | $21.0M | $27.7M | $33.5M | $44.3M | $49.8M | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | -- | -- | $33.5M | $776.0K | $1.0M | ||
| General & Administrative Expenses | -- | $5.1M | $6.9M | $9.2M | $15.6M | $21.0M | $27.7M | $20.8M | $44.3M | $49.8M | ||
| Salaries & Wages | $581.1K | $559.3K | $902.4K | $2.5M | $2.3M | $1.9M | $5.5M | $15.7M | $13.7M | $11.5M | ||
| Depreciation & Amortization | $333.9K | $235.3K | $324.6K | $316.5K | $1.3M | $21.3M | $2.1M | $2.0M | $2.4M | $4.3M | ||
| Depreciation & Amortization | $333.9K | $235.3K | $324.6K | $316.5K | $1.3M | $21.3M | $2.1M | $2.0M | $2.4M | $4.3M | ||
| Amortization | $-261.6K | $-152.5K | $-276.0K | $-258.1K | $-1.1M | $19.2M | $14.9M | $22.8M | $78.4M | $71.1M | ||
| Other Operating Expenses | $3.3M | $5.1M | -- | -- | $-132.0K | $250.2K | $184.7K | $176.6K | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-597.4K | $1.9M | $-2.1M | $180.1K | $-3.7M | $-2.1M | $361.1K | $-12.3M | $-26.4M | $-13.7M | ||
| EBITDA | $-261.2K | $-1.3M | $-1.8M | $542.8K | $-2.9M | $-59.4K | $2.4M | $-7.0M | $-21.1M | $-8.1M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | -- | -- | -- | $1.5M | $6.2M | ||
| Intinc | $2.3K | $42.3K | $25.9K | $46.2K | $288.0K | $68.6K | $17.0K | $852.3K | $2.2M | $329.0K | ||
| Net Non-Operating Interest Income/Expense | $2.3K | $42.3K | $25.9K | $46.2K | $288.0K | $68.6K | $17.0K | $-852.3K | $738.0K | $-5.8M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | $15.7M | $19.1M | $12.2M | -- | -- | ||
| Other Income/Expense | -- | $3.4M | -- | -- | $635.0K | $140.4K | $-17.0K | $-102.6M | $1.6M | $-152.0K | ||
| Other Special Charges | -- | $190.7K | -- | -- | $-635.0K | $-140.4K | $17.0K | $101.4K | $500.0K | $152.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $16.2M | -- | -- | ||
| Special Income Charges | -- | $-50.0K | -- | -- | -- | $-19.2M | -- | $-16.2M | $-6.7M | $-7.5M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $19.2M | -- | -- | $6.7M | $7.5M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-4.0M | $-2.1M | $361.1K | $-9.0M | $-23.7M | $-13.2M | ||
| Pre-Tax Income | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-4.0M | $-2.2M | $378.1K | $-11.4M | $-25.2M | $-19.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-202.0K | $-523.0M | $-715.0K | -- | $-898.0K | $463.0K | $25.7M | $2.4M | $-7.6M | $725.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-3.1M | $-2.2M | $378.1K | $-11.4M | $-17.6M | $-20.1M | ||
| Net Income (Continuing Operations) | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-3.1M | $-2.2M | $378.1K | $-11.4M | $-17.6M | $-20.1M | ||
| Net Income (Discontinued Operations) | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-3.1M | $-2.2M | $378.1K | $-11.4M | $-17.6M | $-20.1M | ||
| Net Income (Common Stockholders) | $-595.1K | $-1.5M | $-2.1M | $226.3K | $-3.1M | $-2.2M | $378.1K | $-11.4M | $-17.6M | $-20.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-573.7K | $-5.9M | $-1.9M | $-21.0M | $-28.3M | $45.4M | $60.9M | $74.7M | $97.9M | $105.8M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $24.6M | $29.7M | $9.8M | $10.8M | $13.4M | $14.8M | $17.2M | $17.8M | $17.1M | $18.3M | ||
| Average Shares Outstanding (Diluted) | $29.8M | $30.8M | $9.8M | $11.9M | $13.4M | $14.8M | $17.7M | $17.8M | $17.1M | $18.3M | ||
| Shares Outstanding | $29.0M | $29.7M | $29.3M | $12.1M | $14.6M | $16.8M | $17.9M | $17.1M | $18.6M | $18.6M | ||
| Basic EPS | $-0.02 | $-0.05 | $-0.21 | $0.02 | $-0.23 | $-0.15 | $0.02 | $-0.64 | $-1.03 | $-1.1 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $0.02 | $-0.23 | $-0.15 | $0.02 | $-0.64 | $-1.03 | $-1.1 | ||
| Diluted EPS | -- | $-0.05 | $-0.21 | $0.02 | $-0.23 | $-0.15 | $0.02 | $-0.64 | $-1.03 | $-1.1 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $0.02 | $-0.23 | $-0.15 | $0.02 | $-0.64 | $-1.03 | $-1.1 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | $6.2M | -- | -- | -- | -- | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | -- | $3.2M | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | -- | -- | -- | -- | $-2.1M | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-2.1M | -- | ||
| Insurance And Claims | -- | -- | -- | -- | -- | -- | -- | $20.0M | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | -- | $3.2M | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-2.1M | -- | ||
| Non Recurring Operation Expense | -- | $50.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | -- | $5.1M | $6.9M | $9.2M | $15.6M | $21.0M | $27.7M | $20.8M | $44.3M | $49.8M | ||
| Other Impairment Of Capital Assets | -- | $3.4M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | -- | $252.7K | -- | -- | ||
| Rent And Landing Fees | -- | $-3.0K | $-2.7K | -- | -- | -- | $5.5M | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | $16.2M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OPRX | $20.49 | +4.5% | 256.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |